Loading...

Penumbra, Inc.

PEN•NYSE
Healthcare
Medical - Devices
$329.89
$-3.11(-0.93%)
U.S. Market opens in 30h 27m

Penumbra, Inc. (PEN) Stock Overview

Explore Penumbra, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap12.9B
P/E Ratio72.85
EPS (TTM)$4.53
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$348.28
3 Months$314.43
1 Year Target$280.73

PEN Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Penumbra, Inc. (PEN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 44.18, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $280.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 72.85 and a market capitalization of 12.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.99%
5-Day Change
-0.65%
1-Month Change
-1.34%
3-Month Change
-8.23%
6-Month Change
30.32%
Year-to-Date (YTD) Change
6.04%
1-Year Change
10.54%
3-Year Change
14.35%
5-Year Change
7.09%
All-Time (Max) Change
698.31%

Contact Information

https://www.penumbrainc.com
510 748 3200
One Penumbra Place, Alameda, CA, 94502

Company Facts

4,500 Employees
IPO DateSep 18, 2015
CountryUS
Actively Trading

Frequently Asked Questions